Drug Treats Aggressive Form of MS

摘要

MORE THAN 400,000 AMERICANS are afflicted with multiple sclerosis, an autoimmune disease that disrupts the brain's neural signals to the body. In March, the Food and Drug Administration approved the drug ocrelizumab to treat not only the milder form of MS, but also the primary-progressive form, for which there was no treatment until now.